| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026955344 |
| P356 | DOI | 10.1038/NSMB.1421 |
| P8608 | Fatcat ID | release_5txhh4upzbbb5flzmvobj5v3da |
| P3181 | OpenCitations bibliographic resource ID | 690764 |
| P698 | PubMed publication ID | 18454157 |
| P5875 | ResearchGate publication ID | 5329836 |
| P50 | author | Stephen Anthony Cusack | Q19914199 |
| Patricia Resa-Infante | Q47087609 | ||
| Darren J Hart | Q54837819 | ||
| Thibaut Crépin | Q59401298 | ||
| P2093 | author name string | Rob W H Ruigrok | |
| Delphine Guilligay | |||
| Joe Lewis | |||
| Peter Sehr | |||
| Patricia Resa-Infante | |||
| Franck Tarendeau | |||
| Juan Ortin | |||
| Rocío Coloma | |||
| P2860 | cites work | Activation of influenza virus-associated RNA polymerase by cap-1 structure (m7GpppNm). | Q45828066 |
| Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains | Q45843152 | ||
| Characterization of a temperature-sensitive mutant in the RNA polymerase PB2 subunit gene of influenza A/WSN/33 virus | Q45850106 | ||
| Genetic variability of Hong Kong (H3N2) influenza viruses: spontaneous mutations and their location in the viral genome. | Q54546412 | ||
| Capped mRNAs may stimulate the influenza virion polymerase by allosteric modulation | Q70771602 | ||
| Large-scale induced fit recognition of an m(7)GpppG cap analogue by the human nuclear cap-binding complex | Q24310463 | ||
| Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system | Q24628961 | ||
| Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins | Q27639133 | ||
| Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit | Q27643860 | ||
| Cocrystal structure of the messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP | Q27739838 | ||
| Structural Basis for Sequence-Nonspecific Recognition of 5′-Capped mRNA by a Cap-Modifying Enzyme | Q27760566 | ||
| Automated protein model building combined with iterative structure refinement | Q27860506 | ||
| Structure validation by Calpha geometry: phi,psi and Cbeta deviation | Q27860657 | ||
| Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin | Q27860688 | ||
| Protein structure comparison by alignment of distance matrices | Q27860798 | ||
| Refinement of macromolecular structures by the maximum-likelihood method | Q27861011 | ||
| Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA polymerase | Q27863658 | ||
| The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits | Q27863698 | ||
| 3D structure of the influenza virus polymerase complex: localization of subunit domains. | Q27863781 | ||
| A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription | Q27865288 | ||
| RNA-dependent activation of primer RNA production by influenza virus polymerase: different regions of the same protein subunit constitute the two required RNA-binding sites | Q27867719 | ||
| Generation of influenza A viruses entirely from cloned cDNAs | Q29616768 | ||
| Influenza: lessons from past pandemics, warnings from current incidents. | Q30351160 | ||
| Antiviral agents active against influenza A viruses. | Q30358429 | ||
| Global patterns of influenza a virus in wild birds | Q33995214 | ||
| Recognition of mRNA cap structures by viral and cellular proteins | Q36098747 | ||
| Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription | Q36396943 | ||
| Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein | Q37093452 | ||
| Differential effect of modified capped RNA substrates on influenza virus transcription | Q38344450 | ||
| Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to human cap binding protein eIF4E. | Q38354500 | ||
| Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding | Q38356589 | ||
| Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification | Q39588564 | ||
| A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs | Q39684553 | ||
| Three-dimensional model for the isolated recombinant influenza virus polymerase heterotrimer | Q40129576 | ||
| Inhibition of influenza viral polymerases by minimal viral RNA decoys | Q41091374 | ||
| Specificity of recognition of mRNA 5' cap by human nuclear cap-binding complex | Q41833043 | ||
| Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle | Q42724088 | ||
| Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding | Q43156905 | ||
| P433 | issue | 5 | |
| P921 | main subject | virus | Q808 |
| P304 | page(s) | 500-6 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Nature Structural & Molecular Biology | Q1071739 |
| P1476 | title | The structural basis for cap binding by influenza virus polymerase subunit PB2 | |
| P478 | volume | 15 |
| Q61449744 | A Comprehensive Review on the Interaction Between the Host GTPase Rab11 and Influenza A Virus |
| Q35674905 | A complete map of potential pathogenicity markers of avian influenza virus subtype H5 predicted from 11 expressed proteins |
| Q91227505 | A convenient in vivo cap donor delivery system to investigate the cap snatching of plant bunyaviruses |
| Q57031885 | A multisubstrate reductase from Plantago major: structure-function in the short chain reductase superfamily |
| Q34139013 | A novel functional site in the PB2 subunit of influenza A virus essential for acetyl-CoA interaction, RNA polymerase activity, and viral replication. |
| Q38766044 | A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication. |
| Q36666497 | A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase. |
| Q98733614 | A prion-like domain in ELF3 functions as a thermosensor in Arabidopsis |
| Q37416358 | A quantitative strategy to detect changes in accessibility of protein regions to chemical modification on heterodimerization |
| Q64116821 | A review of H5Nx avian influenza viruses |
| Q36414388 | A small-RNA enhancer of viral polymerase activity |
| Q47788104 | A structural organization for the Disrupted in Schizophrenia 1 protein, identified by high-throughput screening, reveals distinctly folded regions, which are bisected by mental illness-related mutations |
| Q30429748 | Adaptation of Avian Influenza A Virus Polymerase in Mammals To Overcome the Host Species Barrier |
| Q39355418 | Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells |
| Q38111647 | Adaptive mutations in the H5N1 polymerase complex |
| Q41359819 | Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice |
| Q30395645 | All that glitters is not gold--founder effects complicate associations of flu mutations to disease severity |
| Q38348049 | An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome |
| Q40362747 | An in vitro fluorescence based study of initiation of RNA synthesis by influenza B polymerase |
| Q39136001 | Antiviral activity of Jinchai capsule against influenza virus |
| Q26738562 | Antiviral therapies on the horizon for influenza |
| Q38011755 | Antivirals Targeting Influenza A Virus |
| Q34286309 | Architecture and regulation of negative-strand viral enzymatic machinery |
| Q33769326 | Artificial Hybrids of Influenza A Virus RNA Polymerase Reveal PA Subunit Modulates Its Thermal Sensitivity |
| Q34055461 | Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT. |
| Q28550239 | Atomic Structure and Biochemical Characterization of an RNA Endonuclease in the N Terminus of Andes Virus L Protein |
| Q41919256 | Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Polymerase activity and mechanisms of action of nucleotide analogs |
| Q39319904 | Biochemical principles and inhibitors to interfere with viral capping pathways |
| Q38117553 | Biogenesis, assembly, and export of viral messenger ribonucleoproteins in the influenza A virus infected cell |
| Q30395393 | Biological characterization of highly pathogenic avian influenza H5N1 viruses that infected humans in Egypt in 2014-2015. |
| Q27664646 | Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent Transcription |
| Q39248221 | Bunyaviridae RdRps: structure, motifs, and RNA synthesis machinery |
| Q37940415 | Cap and cap-binding proteins in the control of gene expression |
| Q27665958 | Cap binding and immune evasion revealed by Lassa nucleoprotein structure |
| Q41922860 | Cap snatching of yeast L-A double-stranded RNA virus can operate in trans and requires viral polymerase actively engaging in transcription |
| Q35471074 | Cap-snatching mechanism in yeast L-A double-stranded RNA virus |
| Q47569878 | Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors. |
| Q38959504 | Cellular human CLE/C14orf166 protein interacts with influenza virus polymerase and is required for viral replication. |
| Q34440497 | Cellular protein HAX1 interacts with the influenza A virus PA polymerase subunit and impedes its nuclear translocation |
| Q30426032 | Characterization in vitro and in vivo of a pandemic H1N1 influenza virus from a fatal case. |
| Q42284370 | Characterization of PA-N terminal domain of Influenza A polymerase reveals sequence specific RNA cleavage |
| Q55426854 | Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. |
| Q26799938 | Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases |
| Q33834096 | CoESPRIT: a library-based construct screening method for identification and expression of soluble protein complexes |
| Q27001753 | Common and unique features of viral RNA-dependent polymerases |
| Q28550279 | Comparative Structural and Functional Analysis of Bunyavirus and Arenavirus Cap-Snatching Endonucleases |
| Q27681434 | Comparative structural and functional analysis of orthomyxovirus polymerase cap-snatching domains |
| Q34448295 | Competition between influenza A virus genome segments |
| Q64078428 | Comprehensive mapping of adaptation of the avian influenza polymerase protein PB2 to humans |
| Q41811018 | Computational Studies on the Substrate Interactions of Influenza A Virus PB2 Subunit |
| Q47259261 | Computational analysis of the effect of polymerase acidic (PA) gene mutation F35L in the 2009 pandemic influenza A (H1N1) virus on binding aspects of mononucleotides in the endonuclease domain |
| Q27680799 | Conformational polymorphism of m7GTP in crystal structure of the PB2 middle domain from human influenza A virus |
| Q36946991 | Conserved Endonuclease Function of Hantavirus L Polymerase |
| Q37964471 | Conventional and unconventional mechanisms for capping viral mRNA. |
| Q39730929 | Correlation between polymerase activity and pathogenicity in two duck H5N1 influenza viruses suggests that the polymerase contributes to pathogenicity |
| Q27678055 | Crimean-Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses |
| Q38234789 | Crucial role of PA in virus life cycle and host adaptation of influenza A virus |
| Q27668161 | Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2′-O-Methyltransferase nsp10/nsp16 Complex |
| Q27653656 | Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site |
| Q27315161 | Crystal structure of the RNA-dependent RNA polymerase from influenza C virus |
| Q27651109 | Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus |
| Q36711056 | Crystallization and X-ray crystallographic analysis of the cap-binding domain of influenza A virus H1N1 polymerase subunit PB2 |
| Q37083804 | Crystallization and X-ray diffraction analysis of the RNA primer/promoter-binding domain of influenza A virus RNA-dependent RNA polymerase PB2. |
| Q27681317 | Crystallization and preliminary X-ray diffraction studies of a surface mutant of the middle domain of PB2 from human influenza A (H1N1) virus |
| Q42578086 | Crystallization studies of the keratin-like domain from Arabidopsis thaliana SEPALLATA 3. |
| Q38473543 | Deep sequencing reveals the eight facets of the influenza A/HongKong/1/1968 (H3N2) virus cap-snatching process |
| Q42107951 | Detection and characterization of influenza A virus PA-PB2 interaction through a bimolecular fluorescence complementation assay |
| Q36482772 | Development of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza |
| Q43173299 | Differential host gene responses in mice infected with two highly pathogenic avian influenza viruses of subtype H5N1 isolated from wild birds in Thailand |
| Q30398601 | Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2. |
| Q91800691 | Diversity of A(H5N1) clade 2.3.2.1c avian influenza viruses with evidence of reassortment in Cambodia, 2014-2016 |
| Q34595028 | DnaJA1/Hsp40 is co-opted by influenza A virus to enhance its viral RNA polymerase activity |
| Q33599838 | Dynamical insight into Caenorhabditis elegans eIF4E recognition specificity for mono-and trimethylated structures of mRNA 5' cap. |
| Q51021243 | ESPRIT: A Method for Defining Soluble Expression Constructs in Poorly Understood Gene Sequences |
| Q30356291 | Effects of different polymerases of avian influenza viruses on the growth and pathogenicity of A/Puerto Rico/8/1934 (H1N1)-derived reassorted viruses. |
| Q34269400 | Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex |
| Q30376907 | Emerging antiviral targets for influenza A virus. |
| Q24567974 | Enzymology of RNA cap synthesis |
| Q38061423 | Evasion of influenza A viruses from innate and adaptive immune responses. |
| Q64129782 | Evolution of canine and equine influenza (H3N8) viruses co-circulating between 2005 and 2008 |
| Q28603187 | Evolution of the Plant Reproduction Master Regulators LFY and the MADS Transcription Factors: The Role of Protein Structure in the Evolutionary Development of the Flower |
| Q36409349 | Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors |
| Q33965724 | Experimental mapping of soluble protein domains using a hierarchical approach |
| Q33399907 | Expression of Helicobacter pylori CagA domains by library-based construct screening |
| Q33684517 | Expression of soluble, active fragments of the morphogenetic protein SpoIIE from Bacillus subtilis using a library-based construct screen |
| Q30356104 | Extreme evolutionary conservation of functionally important regions in H1N1 influenza proteome. |
| Q27683683 | First structural evidence of sequestration of mRNA cap structures by type 1 ribosome inactivating protein from Momordica balsamina |
| Q38184248 | Flavivirus RNA methylation |
| Q90949938 | Flupyranochromene, a novel inhibitor of influenza virus cap-dependent endonuclease, from Penicillium sp. f28743 |
| Q35680145 | Functional Constraint Profiling of a Viral Protein Reveals Discordance of Evolutionary Conservation and Functionality |
| Q36736639 | Functional Genomics Reveals Linkers Critical for Influenza Virus Polymerase |
| Q30406897 | Gene Composerin a structural genomics environment |
| Q28118085 | Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network |
| Q40075092 | Genetic and codon usage bias analyses of polymerase genes of equine influenza virus and its relation to evolution. |
| Q33455562 | Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication. |
| Q42276887 | Genomic and evolutionary characterization of a novel influenza-C-like virus from swine |
| Q33955342 | Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse |
| Q42919340 | Genomic diversity of oseltamivir-resistant influenza virus A (H1N1), Luxembourg, 2007-08. |
| Q90434393 | Hantavirus RdRp Requires a Host Cell Factor for Cap Snatching |
| Q33799724 | Hantavirus nucleocapsid protein has distinct m7G cap- and RNA-binding sites |
| Q28477264 | Heat shock protein 70 inhibits the activity of Influenza A virus ribonucleoprotein and blocks the replication of virus in vitro and in vivo |
| Q38268262 | Heat shock protein 70 modulates influenza A virus polymerase activity |
| Q27681674 | High-Resolution Structure of the N-Terminal Endonuclease Domain of the Lassa Virus L Polymerase in Complex with Magnesium Ions |
| Q27651972 | Host Determinant Residue Lysine 627 Lies on the Surface of a Discrete, Folded Domain of Influenza Virus Polymerase PB2 Subunit |
| Q36736357 | Host Protein Moloney Leukemia Virus 10 (MOV10) Acts as a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein |
| Q39451190 | Host immune-related gene responses against highly pathogenic avian influenza virus infection in vitro differ among chicken cell lines established from different organs |
| Q34022729 | Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus. |
| Q30574395 | Identification of Influenza Endonuclease Inhibitors Using a Novel Fluorescence Polarization Assay |
| Q30370990 | Identification of PB2 mutations responsible for the efficient replication of H5N1 influenza viruses in human lung epithelial cells |
| Q28476315 | Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication |
| Q28118856 | Identification of gemin5 as a novel 7-methylguanosine cap-binding protein |
| Q28743238 | Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase |
| Q38325400 | Influence of PB2 host-range determinants on the intranuclear mobility of the influenza A virus polymerase |
| Q56981340 | Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement |
| Q39224928 | Influenza A polymerase subunit PB2 possesses overlapping binding sites for polymerase subunit PB1 and human MAVS proteins. |
| Q39669004 | Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. |
| Q34121115 | Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms |
| Q36286466 | Influenza A virus preferentially snatches noncoding RNA caps |
| Q33953132 | Influenza A virus-generated small RNAs regulate the switch from transcription to replication |
| Q35879897 | Influenza Polymerase Can Adopt an Alternative Configuration Involving a Radical Repacking of PB2 Domains |
| Q34263308 | Influenza polymerase activity correlates with the strength of interaction between nucleoprotein and PB2 through the host-specific residue K/E627. |
| Q30791826 | Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis |
| Q33997127 | Influenza virus infection induces the nuclear relocalization of the Hsp90 co-chaperone p23 and inhibits the glucocorticoid receptor response |
| Q42084631 | Influenza virus polymerase confers independence of the cellular cap-binding factor eIF4E for viral mRNA translation |
| Q38444279 | Influenza virus polymerase: Functions on host range, inhibition of cellular response to infection and pathogenicity. |
| Q41593760 | Influenza: An RNA-synthesizing machine |
| Q37631859 | Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5'-terminal regions of cap0-, cap1- and 5'ppp- mRNAs |
| Q33646273 | Innate immune evasion strategies of influenza viruses |
| Q34574076 | Integrating computational modeling and functional assays to decipher the structure-function relationship of influenza virus PB1 protein |
| Q34695795 | Interaction of the influenza A virus polymerase PB2 C-terminal region with importin alpha isoforms provides insights into host adaptation and polymerase assembly. |
| Q34262049 | Interactions between the influenza A virus RNA polymerase components and retinoic acid-inducible gene I. |
| Q30366402 | Interactome analysis of the influenza A virus transcription/replication machinery identifies protein phosphatase 6 as a cellular factor required for efficient virus replication. |
| Q64077290 | Interplay between Influenza Virus and the Host RNA Polymerase II Transcriptional Machinery |
| Q30375026 | Interplay between influenza A virus and host factors: targets for antiviral intervention. |
| Q36785197 | Interplay between viruses and host mRNA degradation |
| Q92717896 | Inventory of molecular markers affecting biological characteristics of avian influenza A viruses |
| Q90736243 | Key Role of the Influenza A Virus PA Gene Segment in the Emergence of Pandemic Viruses |
| Q93193646 | Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication |
| Q38384758 | Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza |
| Q27008422 | Library methods for structural biology of challenging proteins and their complexes |
| Q33949042 | Library-based methods for identification of soluble expression constructs |
| Q39719150 | Limited compatibility of polymerase subunit interactions in influenza A and B viruses |
| Q28246933 | Mesoionic heterocyclic compounds as candidate messenger RNA cap analogue inhibitors of the influenza virus RNA polymerase cap-binding activity |
| Q41130389 | Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit. |
| Q90281098 | Molecular mechanisms of Evening Complex activity in Arabidopsis |
| Q56556612 | Multiple polymerase gene mutations for human adaptation occurring in Asian H5N1 influenza virus clinical isolates |
| Q28534627 | Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease |
| Q42428242 | Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit |
| Q30414529 | Mutations in polymerase genes enhanced the virulence of 2009 pandemic H1N1 influenza virus in mice |
| Q90020522 | Mutations in the H7 HA and PB1 genes of avian influenza a viruses increase viral pathogenicity and contact transmission in guinea pigs |
| Q91206841 | Mutations of the segment-specific nucleotides at the 3' end of influenza virus NS segment control viral replication |
| Q35011532 | New prospects for the rational design of antivirals |
| Q27314657 | Novel Polymerase Gene Mutations for Human Adaptation in Clinical Isolates of Avian H5N1 Influenza Viruses |
| Q40743239 | Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors |
| Q41713118 | Novel residues in avian influenza virus PB2 protein affect virulence in mammalian hosts |
| Q45325232 | Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation. |
| Q39801069 | Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies |
| Q42165218 | Nuclear localization of influenza B polymerase proteins and their binary complexes |
| Q27646520 | Nucleoside Monophosphate Complex Structures of the Endonuclease Domain from the Influenza Virus Polymerase PA Subunit Reveal the Substrate Binding Site inside the Catalytic Center |
| Q52644426 | Nucleosides for the treatment of respiratory RNA virus infections |
| Q27675228 | Organization of the influenza virus replication machinery |
| Q30395091 | PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice |
| Q30385995 | PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. |
| Q40434822 | PB2 substitutions V598T/I increase the virulence of H7N9 influenza A virus in mammals |
| Q101165964 | Parallel evolution in the emergence of highly pathogenic avian influenza A viruses |
| Q38089861 | Poly(A)-specific ribonuclease (PARN): An allosterically regulated, processive and mRNA cap-interacting deadenylase |
| Q38832421 | Polycistronic Expression of the Influenza A Virus RNA-Dependent RNA Polymerase by Using the Thosea asigna Virus 2A-Like Self-Processing Sequence |
| Q30410407 | Polymerase activity of hybrid ribonucleoprotein complexes generated from reassortment between 2009 pandemic H1N1 and seasonal H3N2 influenza A viruses. |
| Q39091129 | Polymerase complex with lysine at position 627 of the PB2 of influenza virus A/Hong Kong/483/97 (H5N1) efficiently transcribes and replicates virus genes in mouse cells |
| Q97587374 | Pre-initiation and elongation structures of full-length La Crosse virus polymerase reveal functionally important conformational changes |
| Q35076802 | Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit |
| Q40062104 | Prerequisites for the acquisition of mammalian pathogenicity by influenza A virus with a prototypic avian PB2 gene |
| Q92568973 | Priming and realignment by the influenza a virus RdRp is dependent on the length of the host primers and the extent of base pairing to viral RNA |
| Q30234943 | Progress of small molecular inhibitors in the development of anti-influenza virus agents |
| Q92730130 | Quantifying within-host diversity of H5N1 influenza viruses in humans and poultry in Cambodia |
| Q38100767 | RNA synthetic mechanisms employed by diverse families of RNA viruses |
| Q33641550 | RNA virus replication complexes |
| Q90633475 | Rank orders of mammalian pathogenicity-related PB2 mutations of avian influenza A viruses |
| Q26863710 | Recent progress in structure-based anti-influenza drug design |
| Q38335070 | Recognition of Cap Structure by Influenza B Virus RNA Polymerase Is Less Dependent on the Methyl Residue than Recognition by Influenza A Virus Polymerase |
| Q42130090 | Regulation of Influenza RNA Polymerase Activity and the Switch between Replication and Transcription by the Concentrations of the vRNA 5′ End, the Cap Source, and the Polymerase |
| Q56427023 | Replication Cycle of Influenza Viruses |
| Q30431677 | Replication and Transcription Activities of Ribonucleoprotein Complexes Reconstituted from Avian H5N1, H1N1pdm09 and H3N2 Influenza A Viruses |
| Q26746999 | Replication-Competent Influenza A Viruses Expressing Reporter Genes |
| Q30387215 | Residues in the PB2 and PA genes contribute to the pathogenicity of avian H7N3 influenza A virus in DBA/2 mice. |
| Q46281156 | Rice Stripe Tenuivirus Has a Greater Tendency To Use the Prime-and-Realign Mechanism in Transcription of Genomic than in Transcription of Antigenomic Template RNAs |
| Q38994875 | Role of the C terminus of Lassa virus L protein in viral mRNA synthesis |
| Q38998940 | Role of the PB2 627 Domain in Influenza A Virus Polymerase Function |
| Q36044129 | Secondary Structure Prediction of Protein Constructs Using Random Incremental Truncation and Vacuum-Ultraviolet CD Spectroscopy |
| Q38883679 | Sequencing the cap-snatching repertoire of H1N1 influenza provides insight into the mechanism of viral transcription initiation. |
| Q42326378 | Signatures of Host mRNA 5′ Terminus for Efficient Hantavirus Cap Snatching |
| Q30414976 | Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase |
| Q37825059 | So similar, yet so different: selective translation of capped and polyadenylated viral mRNAs in the influenza virus infected cell |
| Q27671365 | Structural Analysis of Specific Metal Chelating Inhibitor Binding to the Endonuclease Domain of Influenza pH1N1 (2009) Polymerase |
| Q27667486 | Structural Basis for Microcin C7 Inactivation by the MccE Acetyltransferase |
| Q27653426 | Structural Basis of the Influenza A Virus RNA Polymerase PB2 RNA-binding Domain Containing the Pathogenicity-determinant Lysine 627 Residue |
| Q27671357 | Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease |
| Q27676615 | Structural and Functional Characterization of K339T Substitution Identified in the PB2 Subunit Cap-binding Pocket of Influenza A Virus |
| Q34178189 | Structural and functional characterization of an influenza virus RNA polymerase-genomic RNA complex |
| Q27655083 | Structural basis for m7G-cap hypermethylation of small nuclear, small nucleolar and telomerase RNA by the dimethyltransferase TGS1 |
| Q43258764 | Structural basis for oseltamivir resistance of influenza viruses |
| Q33359110 | Structural basis for the oligomerization of the MADS domain transcription factor SEPALLATA3 in Arabidopsis |
| Q40071053 | Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit. |
| Q40370553 | Structural characterization of recombinant IAV polymerase reveals a stable complex between viral PA-PB1 heterodimer and host RanBP5. |
| Q27696194 | Structural insight into cap-snatching and RNA synthesis by influenza polymerase |
| Q27655568 | Structural insight into the essential PB1–PB2 subunit contact of the influenza virus RNA polymerase |
| Q39099407 | Structural insights into RNA synthesis by the influenza virus transcription-replication machine |
| Q36372058 | Structural insights into reptarenavirus cap-snatching machinery. |
| Q38090250 | Structure and assembly of the influenza A virus ribonucleoprotein complex |
| Q92343247 | Structure of a functional cap-binding domain in Rift Valley fever virus L protein |
| Q42181164 | Structure of influenza A polymerase bound to the viral RNA promoter |
| Q93270615 | Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation |
| Q38924212 | Structure of the Lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy |
| Q37496812 | Structure-function studies of the influenza virus RNA polymerase PA subunit |
| Q30387969 | Structures of influenza A proteins and insights into antiviral drug targets. |
| Q30369689 | Survival analysis of infected mice reveals pathogenic variations in the genome of avian H1N1 viruses |
| Q42627674 | Synergistic effect of PB2 283M and 526R contributes to enhanced virulence of H5N8 influenza viruses in mice |
| Q38333995 | Synthesis of a new class of ribose functionalized dinucleotide cap analogues for biophysical studies on interaction of cap-binding proteins with the 5′ end of mRNA |
| Q59830619 | Targeting Metalloenzymes for Therapeutic Intervention |
| Q39466061 | Targeting of the Influenza A Virus Polymerase PB1-PB2 Interface Indicates Strain-Specific Assembly Differences |
| Q38047645 | Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection |
| Q57466491 | Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine |
| Q26744324 | The Feat of Packaging Eight Unique Genome Segments |
| Q28071809 | The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design |
| Q39799773 | The Myb domain of LUX ARRHYTHMO in complex with DNA: expression, purification and crystallization. |
| Q30395961 | The N terminus of PA polymerase of swine-origin influenza virus H1N1 determines its compatibility with PB2 and PB1 subunits through a strain-specific amino acid serine 186 |
| Q27664647 | The N-Terminal Domain of the Arenavirus L Protein Is an RNA Endonuclease Essential in mRNA Transcription |
| Q33440587 | The N-terminal region of the PA subunit of the RNA polymerase of influenza A/HongKong/156/97 (H5N1) influences promoter binding |
| Q38963385 | The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses |
| Q34055501 | The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon |
| Q27673499 | The Protein Maker: an automated system for high-throughput parallel purification |
| Q30413814 | The RNA Polymerase PB2 Subunit of Influenza A/HongKong/156/1997 (H5N1) Restrict the Replication of Reassortant Ribonucleoprotein Complexes |
| Q28084418 | The RNA synthesis machinery of negative-stranded RNA viruses |
| Q39093232 | The RNA-dependent RNA polymerase of the influenza A virus |
| Q34082693 | The Splicing Factor Proline-Glutamine Rich (SFPQ/PSF) Is Involved in Influenza Virus Transcription |
| Q57094150 | The Surface-Exposed PA-Loop of the Influenza A Virus Polymerase Is Required for Viral Genome Replication |
| Q37708361 | The VIZIER project: overview; expectations; and achievements |
| Q30384645 | The cap-binding site of influenza virus protein PB2 as a drug target. |
| Q27653657 | The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit |
| Q30371858 | The crystal structure of the PB2 cap-binding domain of influenza B virus reveals a novel cap recognition mechanism. |
| Q40161983 | The highly pathogenic H5N1 influenza A virus down-regulated several cellular MicroRNAs which target viral genome. |
| Q33391385 | The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication |
| Q34740501 | The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit |
| Q30403251 | The influenza pandemic of 2009: lessons and implications |
| Q37847896 | The influenza virus RNA synthesis machine: advances in its structure and function |
| Q59352771 | The nucleolar protein LYAR facilitates ribonucleoprotein assembly of influenza A virus |
| Q26824373 | The polymerase of negative-stranded RNA viruses |
| Q37823112 | The role of the influenza virus RNA polymerase in host shut-off |
| Q27651365 | The structural basis for an essential subunit interaction in influenza virus RNA polymerase |
| Q27316702 | The structure of a biologically active influenza virus ribonucleoprotein complex |
| Q38064834 | Tinkering with Translation: Protein Synthesis in Virus-Infected Cells |
| Q26772953 | Towards a structural understanding of RNA synthesis by negative strand RNA viral polymerases |
| Q28354200 | Tracking the Evolution of Polymerase Genes of Influenza A Viruses during Interspecies Transmission between Avian and Swine Hosts |
| Q39110012 | Transcription and replication mechanisms of Bunyaviridae and Arenaviridae L proteins |
| Q45361252 | Two mutations in the C-terminal domain of influenza virus RNA polymerase PB2 enhance transcription by enhancing cap-1 RNA binding activity |
| Q37415425 | Ubiquitination up-regulates influenza virus polymerase function. |
| Q42273561 | Understanding molecular mechanisms of traditional Chinese medicine for the treatment of influenza viruses infection by computational approaches |
| Q38664267 | Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA. |
| Q28308081 | Upolu virus and Aransas Bay virus, two presumptive bunyaviruses, are novel members of the family Orthomyxoviridae |
| Q44856323 | Virology: One protein, many functions |
| Q30424508 | Virulence Determinants of Pandemic A(H1N1)2009 Influenza Virus in a Mouse Model |
| Q38364349 | hCLE/C14orf166, a cellular protein required for viral replication, is incorporated into influenza virus particles. |
| Q36479667 | pp32 and APRIL are host cell-derived regulators of influenza virus RNA synthesis from cRNA. |
Search more.